CTIS2023-509450-55-01进行中（未招募）1 期
Prevention of CKD progression in type 1 diabetes with Long term Use of SGLTi avoiding kidney hypOxia (PLUTO)
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 69
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Adults with type 1 diabetes mellitus, Chronic Kidney Disease and albuminuria
排除标准
- •Non-diabetic Kidney Disease, eGFR<25mL/min/1.73m^2, dialysis or kidney transplantation, Previous diabetic ketoacidosis, except at debut, Receiving therapy with an SGLT inhibitor within 8 weeks prior to enrolment or previous intolerence of an SGLT inhibitor.
研究者
相似试验
招募中
2 期
PLUTO - Prevention of CKD progression in type 1 diabetes with Long term Use of SGLTi avoiding kidney hypOxia2023-509450-55-01Steno Diabetes Center Copenhagen39
已完成
不适用
The prevention of progression in CKD of medication adherence to AST-120 in patients with non-dialysis chronic kidney disease (CKD) and significance of measurement indoxyl sulfate as an indicator of medication adherencenon-dialysis chronic kidney diseaseJPRN-UMIN000023724Jichi Medical University100
进行中（未招募）
不适用
Mediterranean diet to prevent type 2 diabetes in mothers who had diabetes in pregnancy: a feasibility studyGestational diabetesPregnancy and ChildbirthISRCTN40582975Queen Mary University of London83
进行中（未招募）
不适用
Religious leaders and diabetes prevention in BangladeshPrevention of diabetesNutritional, Metabolic, EndocrineISRCTN91564707Ministry of Health and Family Welfare824
进行中（未招募）
1 期
PRODIG : Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early post-transplant periodrenal transplantMedDRA version: 20.0Level: SOCClassification code: 10038359Term: Renal and urinary disorders Class: 18CTIS2024-516272-14-00Centre Hospitalier Regional Universitaire186